December 10, 2021 – U.S. surgical procedure volumes rebounded quickly after the initial COVID-19 shutdown in March and April 2020, pointing to the ability of health systems to self-regulate and function at pre-pandemic capacity, reports MedTechDive.
The study findings from a research paper published Wednesday in JAMA Network Open are in line with the experiences of procedure-dependent medtech companies such as NuVasive, which saw sales rebound faster than expected in May and June 2020 and bested analyst expectations.
That experience led analysts to expect a similarly swift recovery from the delta variant wave. However, the delta wave also affected surgeries, both in the U.S. and overseas, and this time around the recovery is slower. Medtronic, one of the latest companies to comment on volumes, said it saw “some improvement” in November but warned factors such as the “critical staffing shortage in hospitals around the world” is slowing the recovery…